Gemcitabine plus Oxaliplatin (GEMOXI): a feasible treatment in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Corradini, G. M. [1 ]
Candido, P. [1 ]
Della Torre, S. [1 ]
Zannier, F. [1 ]
Cozzi, C. [1 ]
Belloni, P. [1 ]
Toniolo, D. [1 ]
Bollina, R. [1 ]
Tagliaferro, G. [1 ]
机构：
[1] Azienda Osped G Salvini, Div Med Oncol, Rho, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 72卷
关键词：
D O I：
10.1016/S1040-8428(09)70146-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [31] Reinitiating nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Borazanci, Erkut
    Schroeder, Katy
    Jameson, Gayle S.
    Ramanathan, Ramesh K.
    Von Hoff, Daniel D.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [32] Phase II Study of Gemcitabine, Oxaliplatin, and Cetuximab in Advanced Pancreatic Cancer
    Merchan, Jaime R.
    Ferrell, Annaporna
    Macintyre, Jessica
    Ciombor, Kristen K.
    Levi, Joe
    Ribeiro, Afonso
    Sleeman, Danny
    Flores, Aurea
    Lopes, Gilberto
    Rocha-Lima, Caio M.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (05): : 446 - 450
  • [33] Chemoradiotherapy after gemcitabine plus erlotinib in patients with locally advanced pancreatic cancer
    Kim, Eunji
    Kim, Kyubo
    Chie, Eui Kyu
    Oh, Do-Youn
    Kim, Yong Tae
    JOURNAL OF BUON, 2017, 22 (04): : 1046 - 1052
  • [34] Phase II trial of bevacizurnab plus gemcitabine in patients with advanced pancreatic cancer
    Kindler, HL
    Friberg, G
    Singh, DA
    Locker, G
    Nattam, S
    Kozloff, M
    Taber, DA
    Karrison, T
    Dachman, A
    Stadler, WM
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) : 8033 - 8040
  • [35] Transarterial infusion with gemcitabine and oxaliplatin for the treatment of unresectable pancreatic cancer
    Chen, Yi
    Wang, Xiao-Lin
    Wang, Jian-Hua
    Yan, Zhi-Ping
    Cheng, Jie-Min
    Gong, Gao-Quan
    Liu, Ling-Xiao
    Li, Guo-Ping
    Li, Chang-Yu
    ANTI-CANCER DRUGS, 2014, 25 (08) : 958 - 963
  • [36] Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
    Cunningham, David
    Chau, Ian
    Stocken, Deborah D.
    Valle, Juan W.
    Smith, David
    Steward, William
    Harper, Peter G.
    Dunn, Janet
    Tudur-Smith, Catrin
    West, Julia
    Falk, Stephen
    Crellin, Adrian
    Adab, Fawzi
    Thompson, Joyce
    Leonard, Pauline
    Ostrowski, Joe
    Eatock, Martin
    Scheithauer, Werner
    Herrmann, Richard
    Neoptolemos, John P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (33) : 5513 - 5518
  • [37] Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
    Isayama, Hiroyuki
    Nakai, Yousuke
    Yamamoto, Keisuke
    Sasaki, Takashi
    Mizuno, Suguru
    Yagioka, Hiroshi
    Yashima, Yoko
    Kawakubo, Kazumichi
    Kogure, Hirofumi
    Arizumi, Toshihiko
    Togawa, Osamu
    Ito, Yukiko
    Matsubara, Saburo
    Yamamoto, Natsuyo
    Sasahira, Naoki
    Hirano, Kenji
    Tsujino, Takeshi
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    ONCOLOGY, 2011, 80 (1-2) : 97 - 101
  • [38] Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer
    Eileen M O'Reilly
    Ghassan K Abou-Alfa
    Nature Clinical Practice Oncology, 2008, 5 : 312 - 313
  • [39] A dose escalation study of gemcitabine plus oxaliplatin in combination with imatinib for gemcitabine-refractory advanced pancreatic adenocarcinoma
    Starling, N.
    Hawkes, E. A.
    Chau, I.
    Watkins, D.
    Thomas, J.
    Webb, J.
    Brown, G.
    Thomas, K.
    Barbachano, Y.
    Oates, J.
    Cunningham, D.
    ANNALS OF ONCOLOGY, 2012, 23 (04) : 942 - 947
  • [40] Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer
    O'Reilly, E. M.
    Abou-Alfa, G. K.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (06): : 312 - 313
12345